DA-6034

· Dong-A Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DA-6034, covering 2013-03-22 to 2014-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers [Phase 1]